These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33062071)

  • 41. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic role of neutrophil-to-lymphocyte ratio to laryngeal squamous cell carcinoma: a meta-analysis.
    Zhao Y; Qin J; Qiu Z; Guo J; Chang W
    Braz J Otorhinolaryngol; 2022; 88(5):717-724. PubMed ID: 33272836
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypoxia dynamics on FMISO-PET in combination with PD-1/PD-L1 expression has an impact on the clinical outcome of patients with Head-and-neck Squamous Cell Carcinoma undergoing Chemoradiation.
    Rühle A; Grosu AL; Wiedenmann N; Mix M; Stoian R; Niedermann G; Baltas D; Werner M; Weber WA; Kayser G; Nicolay NH
    Theranostics; 2020; 10(20):9395-9406. PubMed ID: 32802199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The microRNA-375 as a potentially promising biomarker to predict the prognosis of patients with head and neck or esophageal squamous cell carcinoma: a meta-analysis.
    Wang P; Xu L; Li L; Ren S; Tang J; Zhang M; Xu M
    Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):957-968. PubMed ID: 30747316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis.
    Takenaka Y; Oya R; Kitamiura T; Ashida N; Shimizu K; Takemura K; Yamamoto Y; Uno A
    Head Neck; 2018 Mar; 40(3):647-655. PubMed ID: 29076207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of methylation-driven genes for predicting the prognosis of patients with head and neck squamous cell carcinoma.
    Pan Y; Song Y; Cheng L; Xu H; Liu J
    J Cell Biochem; 2019 Dec; 120(12):19482-19495. PubMed ID: 31264288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hallmarks of cancer: Tumor budding as a sign of invasion and metastasis in head and neck cancer.
    Mäkitie AA; Almangush A; Rodrigo JP; Ferlito A; Leivo I
    Head Neck; 2019 Oct; 41(10):3712-3718. PubMed ID: 31328847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patients.
    Bandurska-Luque A; Löck S; Haase R; Richter C; Zöphel K; Abolmaali N; Seidlitz A; Appold S; Krause M; Steinbach J; Kotzerke J; Zips D; Baumann M; Troost EGC
    Radiother Oncol; 2019 Jan; 130():97-103. PubMed ID: 30293643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
    Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human papillomavirus and p16 immunostaining, prevalence and prognosis of squamous carcinoma of unknown primary in the head and neck region.
    Ren J; Yang W; Su J; Ren X; Fazelzad R; Albert T; Habbous S; Goldstein DP; de Almeida JR; Hansen A; Jang R; Bratman SV; Hope A; Chen R; Wang J; Xu Y; Cheng D; Zhao Y; Xu W; Liu G
    Int J Cancer; 2019 Sep; 145(6):1465-1474. PubMed ID: 30698281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic and prognostic value of circRNAs expression in head and neck squamous cell carcinoma: A meta-analysis.
    Feng H; Wang D; Liu J; Zou L; Xu S; Liang Z; Qin G
    J Clin Lab Anal; 2022 Jul; 36(7):e24496. PubMed ID: 35595945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic Value of Microvessel Density in Non-Hodgkin Lymphoma: A Meta-Analysis.
    Wu J; Ma S; Sun L; Qin Z; Wang Z; Wang N; Lin M
    Acta Haematol; 2021; 144(6):603-612. PubMed ID: 34044389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of systemic inflammatory marker in patients with head and neck squamous cell carcinoma undergoing surgical resection.
    Zhou S; Yuan H; Wang J; Hu X; Liu F; Zhang Y; Jiang B; Zhang W
    Future Oncol; 2020 Apr; 16(10):559-571. PubMed ID: 32166977
    [No Abstract]   [Full Text] [Related]  

  • 54. High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy.
    Chandrasekara S; Davis S; Thomson P; Haydon A
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e442-e447. PubMed ID: 29345108
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma.
    Mroz EA; Patel KB; Rocco JW
    Cancer; 2020 Jan; 126(9):1895-1904. PubMed ID: 32083741
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients.
    Laban S; Gangkofner DS; Holzinger D; Schroeder L; Eichmüller SB; Zörnig I; Jäger D; Wichmann G; Dietz A; Broglie MA; Herold-Mende CC; Dyckhoff G; Boscolo-Rizzo P; Ezić J; Marienfeld R; Möller P; Kraus JM; Völkel G; Kestler HA; Brunner C; Schuler PJ; Wigand MC; Theodoraki MN; Doescher J; Hoffmann TK; Pawlita M; Waterboer T; Butt J
    Clin Cancer Res; 2019 Dec; 25(24):7405-7412. PubMed ID: 31444248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database.
    Gootee J; Patel M; Aurit S; Silberstein P
    Clin Transl Oncol; 2020 Dec; 22(12):2264-2274. PubMed ID: 32440914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis.
    Zhou C; Shen Z; Ye D; Li Q; Deng H; Liu H; Li J
    Cell Physiol Biochem; 2018; 50(3):868-882. PubMed ID: 30355925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lymph node ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinoma.
    Sano D; Yabuki K; Takahashi H; Arai Y; Chiba Y; Tanabe T; Nishimura G; Oridate N
    Auris Nasus Larynx; 2018 Aug; 45(4):846-853. PubMed ID: 29203318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma.
    Pardo L; Valero C; López M; García J; Camacho M; Quer M; León X
    Auris Nasus Larynx; 2017 Jun; 44(3):313-318. PubMed ID: 27401121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.